UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Neuropsychopharmacology (New York, N.Y.), 2015-01, Vol.40 (2), p.259-267

2015

Volltextzugriff (PDF)

Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging

Biological psychiatry (1969), 2015-02, Vol.77 (4), p.385-393

2015

Volltextzugriff (PDF)

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

Molecular psychiatry, 2019-12, Vol.24 (12), p.1779-1786

2019

Volltextzugriff (PDF)

High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression

Brain (London, England : 1878), 2018-03, Vol.141 (3), p.e18-e18

2018

Volltextzugriff (PDF)

Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus

Biological psychiatry (1969), 2007-09, Vol.62 (5), p.429-437

2007

Volltextzugriff (PDF)

Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

Neuropsychopharmacology (New York, N.Y.), 2006-09, Vol.31 (9), p.1841-1853

2006

Volltextzugriff (PDF)

Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

Neuropsychopharmacology (New York, N.Y.), 2006-03, Vol.31 (3), p.628-636

2006

Volltextzugriff (PDF)

Cortisol Circadian Rhythm Alterations in Psychotic Major Depression

Biological psychiatry (1969), 2006-08, Vol.60 (3), p.275-281

2006

Volltextzugriff (PDF)

In Memoriam of George Gardos, MD

Neuropsychopharmacology (New York, N.Y.), 2020-05, Vol.45 (6), p.1080-1080

Schatzberg, Alan F

2020

Volltextzugriff (PDF)

The why, when, where, how, and so what of so-called rapidly acting antidepressants

Neuropsychopharmacology (New York, N.Y.), 2024-01, Vol.49 (1), p.189-196

2024

Volltextzugriff (PDF)

Developmental cascades linking stress inoculation, arousal regulation, and resilience

Frontiers in behavioral neuroscience, 2009-01, Vol.3, p.32-32

2009

Volltextzugriff (PDF)

Altered choroid plexus gene expression in major depressive disorder

Frontiers in human neuroscience, 2014-04, Vol.8, p.238-238

2014

Volltextzugriff (PDF)

Proteomic profiles of cytokines and chemokines in moderate to severe depression: Implications for comorbidities and biomarker discovery

Brain, behavior, & immunity. Health, 2024-03, Vol.36, p.100731-100731, Article 100731

2024

Volltextzugriff (PDF)

Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function

Psychoneuroendocrinology, 2009-08, Vol.34 (7), p.1012-1018

2009

Volltextzugriff (PDF)

Issues encountered in recent attempts to develop novel antidepressant agents

Annals of the New York Academy of Sciences, 2015-05, Vol.1345 (1), p.67-73

Schatzberg, Alan F.

2015

Volltextzugriff (PDF)

NMDA antagonist treatment of depression

Current opinion in neurobiology, 2016-02, Vol.36, p.112-117

2016

Volltextzugriff (PDF)

Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al

Molecular psychiatry, 2021-11, Vol.26 (11), p.6104-6106

2021

Volltextzugriff (PDF)

Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study

Hippocampus, 2003, Vol.13 (1), p.164-174

2003

Volltextzugriff (PDF)

Ecological validity of social defeat stressors in mouse models of vulnerability and resilience

Neuroscience and biobehavioral reviews, 2023-02, Vol.145, p.105032-105032, Article 105032

2023

Volltextzugriff (PDF)

Long-term effects of intermittent early life stress on primate prefrontal-subcortical functional connectivity

Neuropsychopharmacology (New York, N.Y.), 2021-06, Vol.46 (7), p.1348-1356

2021

Volltextzugriff (PDF)

Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial

Neuropsychopharmacology (New York, N.Y.), 2021-03, Vol.46 (4), p.809-819

2021

Volltextzugriff (PDF)

Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis

Psychoneuroendocrinology, 2019-12, Vol.110, p.104420-104420, Article 104420

2019

Volltextzugriff (PDF)

Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder

Frontiers in neuroscience, 2012-01, Vol.6, p.135-135

2012

Volltextzugriff (PDF)

Learning to actively cope with stress in female mice

Psychoneuroendocrinology, 2018-10, Vol.96, p.78-83

2018

Volltextzugriff (PDF)

Decoding the temporal nature of brain GR activity in the NFκB signal transition leading to depressive-like behavior

Molecular psychiatry, 2021-09, Vol.26 (9), p.5087-5096

2021

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Neurosciences
(53)
Psychiatry
(44)
Humans
(28)
Animals
(23)
Male
(23)
Female
(22)
Biological And Medical Sciences
(21)
Psychology. Psychoanalysis. Psychiatry
(18)
Depression
(16)
Stress
(14)
Antidepressive Agents - Therapeutic Use
(13)
Saimiri
(13)
Medical Sciences
(12)
Pharmacology & Pharmacy
(12)
Hydrocortisone - Blood
(11)
Adrenocorticotropic Hormone - Blood
(10)
Clinical Neurology
(10)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression

Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus

Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression

Cortisol Circadian Rhythm Alterations in Psychotic Major Depression

In Memoriam of George Gardos, MD

The why, when, where, how, and so what of so-called rapidly acting antidepressants

Developmental cascades linking stress inoculation, arousal regulation, and resilience

Altered choroid plexus gene expression in major depressive disorder

Proteomic profiles of cytokines and chemokines in moderate to severe depression: Implications for comorbidities and biomarker discovery

Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function

Issues encountered in recent attempts to develop novel antidepressant agents

NMDA antagonist treatment of depression

Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al

Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study

Ecological validity of social defeat stressors in mouse models of vulnerability and resilience

Long-term effects of intermittent early life stress on primate prefrontal-subcortical functional connectivity

Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial

Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis

Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder

Learning to actively cope with stress in female mice

Decoding the temporal nature of brain GR activity in the NFκB signal transition leading to depressive-like behavior

Aktive Filter

Suchergebnisse filtern